Jeff Michalski, MD, MBA

Radiation Oncologist

Primary Academic Title

Carlos A. Perez Distinguished Professor and Vice Chair of Radiation Oncology, Washington University School of Medicine

Clinical Expertise

Prostate, kidney and bladder cancer; pediatric cancer; sarcoma; prostate brachytherapy

Research Interest

Pediatric radiation oncology, conformal radiotherapy, radiation oncology, quality assurance, genitourinary radiation oncology. Key words: Genitourinary cancer, prostate cancer, radiation therapy, IMRT, conformal, radiation, dose escalation, tate effects, pediatric cancer, medulloblastoma, normal tissue effect modeling, quality of life, clinical trials.

Education

1986: MD, Medical College of Wisconsin, Milwaukee

Training

1986 - 1988: Resident, internal medicine and radiation oncology, Columbia-Presbyterian Medical Center, New York
1988 - 1990: Resident, radiation oncology, Washington University, St. Louis
1990 - 1991: Clinical instructor/fellow, radiation oncology, Washington University

Board Certification

1991: American Board of Radiology, Radiation Oncology

Selected Research Publications

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).

Ma TM, Chu FI, Sandler H, [...] Michalski JM, [...] Kishan AU
Eur Urol 2022

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.

Flaig TW, Spiess PE, Abern M, [...] Michalski J, [...] Gurski LA
J Natl Compr Canc Netw 2022

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.

Kishan AU, Wang X, Sun Y, [...] Michalski JM, [...] Spratt DE
Eur Urol 2022

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.

Esteva A, Feng J, van der Wal D, [...] Michalski JM, [...] Mohamad O
NPJ Digit Med 2022

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.

Pollack A, Karrison TG, Balogh AG, [...] Michalski JM, [...] Sandler HM
Lancet 2022

Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.

Schöder H, Hope TA, Knopp M, [...] Michalski JM, [...] Shankar LK
J Clin Oncol 2022

Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone.

Andruska N, Fischer-Valuck BW, Carmona R, [...] Michalski JM, Baumann BC
J Natl Compr Canc Netw 2022

Implementation of Magnetic Resonance Safety Program for Radiation Oncology.

Gach HM, Green OL, Mackey SL, [...] Michalski JM
Pract Radiat Oncol 2022

Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.

Ma TM, Romero T, Nickols NG, [...] Michalski JM, [...] Kishan AU
JAMA Netw Open 2021

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.

Leary SES, Packer RJ, Li Y, [...] Michalski J, [...] Olson JM
JAMA Oncol 2021

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.

Michalski JM, Janss AJ, Vezina LG, [...] Northcott PA
J Clin Oncol 2021

Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade.

Abou DS, Fears A, Summer L, [...] Michalski J, [...] Thorek DL
J Nucl Med 2021

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.

Jairath NK, Dal Pra A, Vince R, [...] Michalski JM, [...] Spratt DE
Eur Urol 2021

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.

Spratt DE, Malone S, Roy S, [...] Michalski J, [...] Lawton CAF
J Clin Oncol 2021

View All Publications

Contact Information

Washington University Medical Campus

4921 Parkview Place
Saint Louis, MO 63110

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment